Carbonic Anhydrase IX: A Renewed Target for Cancer Immunotherapy

SIMPLE SUMMARY: Carbonic anhydrase IX (CAIX) has been explored for a long time as a therapeutic target in the fight against clear cell renal cell carcinoma and several hypoxic tumors, usually offering modest results followed by adverse effects. However, recent studies using different antibodies and...

Descripción completa

Detalles Bibliográficos
Autores principales: de Campos, Najla Santos Pacheco, Souza, Bruna Santos, da Silva, Giselle Correia Próspero, Porto, Victoria Alves, Chalbatani, Ghanbar Mahmoodi, Lagreca, Gabriela, Janji, Bassam, Suarez, Eloah Rabello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946730/
https://www.ncbi.nlm.nih.gov/pubmed/35326544
http://dx.doi.org/10.3390/cancers14061392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946730/
https://www.ncbi.nlm.nih.gov/pubmed/35326544
http://dx.doi.org/10.3390/cancers14061392

Ejemplares similares